Clinical Trial Update: Children, Perennial Allergic Rhinitis (PAR), l-t Growth [Phase 4]

View source ↗

Summary

This is a completed Phase 4 clinical trial evaluating l-t Growth in children with perennial allergic rhinitis. The study was sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• l-t Growth

Snippet

Sponsor: AstraZeneca | Conditions: Perennial Allergic Rhinitis | Phase 4 | Status: COMPLETED